| Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease (NCT02947893) | Georgetown University | 2017-01-01 |
| 2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension) (NCT02916056) | vTv Therapeutics | 2016-12-01 |
| 18F-AV-1451 High Resolution Autopsy Study (NCT02350634) | Avid Radiopharmaceuticals | 2016-11-26 |
| Investigating the Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) as a Treatment for Alzheimer's Disease (NCT02908815) | University of Manitoba | 2016-11-01 |
| Early Identification of Markers in Alzheimer's Families / ALFA (NCT02485730) | Barcelonabeta Brain Research Center, Pasqual Maragall Foundation | 2016-10-25 |
| A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease (NCT02956486) | Eisai Co., Ltd. | 2016-10-20 |
| An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016) (NCT02910739) | Merck Sharp & Dohme LLC | 2016-10-11 |
| Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease (NCT02600130) | Longeveron Inc. | 2016-10-10 |
| Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia (NCT02910102) | Axovant Sciences Ltd. | 2016-10-01 |
| Z-Drugs for Sleep Disorders in Alzheimer's Disease (NCT03075241) | Brasilia University Hospital | 2016-10-01 |
| Optimizing Dementia Care (NCT02585232) | VA Office of Research and Development | 2016-10-01 |
| CPC-201 Alzheimer's Disease Type Dementia: PET Study (NCT02860065) | Chase Pharmaceuticals Corporation, an affiliate of Allergan plc | 2016-09-30 |
| A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease (NCT02912936) | University of British Columbia | 2016-09-01 |
| Identification of Epigenetic Markers Common to Obesity and Alzheimer's Disease in Women (NCT02868905) | Central Hospital, Nancy, France | 2016-09-01 |
| Evaluation of the Safety and Potential Therapeutic Effects of CB-AC-02 in Patients With Alzheimer's Disease (NCT02899091) | CHABiotech CO., Ltd | 2016-09-01 |
| Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease (NCT02907567) | Cognition Therapeutics | 2016-09-01 |
| Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05 (NCT02795780) | Avid Radiopharmaceuticals | 2016-08-01 |
| Adaptive Cognitive Training in Healthy Older Adults (NCT02205710) | Bruyère Health Research Institute. | 2016-08-01 |
| Evaluation of [18F]RO6958948 as Tracer for Positron Emission Tomography (PET) Imaging of Tau Burden in Alzheimer's Disease Participants (NCT02792179) | Hoffmann-La Roche | 2016-07-19 |
| Implications for Management of PET Amyloid Classification Technology in the Imaging Dementia(IDEAS) Trial (NCT02781220) | University of Utah | 2016-07-01 |
| Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases. (NCT02750982) | Brown, Theodore R., M.D., MPH | 2016-07-01 |
| Aftobetin-HCl and Fluorescence Detection Measured by Sapphire II to Determine the Number and Timing of Administrations (NCT02928211) | Cognoptix, Inc. | 2016-07-01 |
| A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia (NCT02783573) | AstraZeneca | 2016-07-01 |
| A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease (NCT02820896) | Genentech, Inc. | 2016-06-29 |
| A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia (NCT02791191) | Eli Lilly and Company | 2016-06-16 |
| Implications for Management of PET Amyloid Classification Technology (NCT02778971) | University of Utah | 2016-06-01 |
| A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female Subjects (NCT02840279) | Tetra Discovery Partners | 2016-06-01 |
| Imaging Inflammation in Alzheimer's Disease (NCT02831283) | Patrick Lao | 2016-06-01 |
| Biomarkers in Neural Disorders (NCT02761707) | University of Pennsylvania | 2016-06-01 |
| A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease (NCT02760602) | Eli Lilly and Company | 2016-06-01 |
| Therapeutic Efficacy of Categorical Language Fluency Smartphone Game Application (NCT02848404) | Seoul National University Bundang Hospital | 2016-06-01 |
| PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases (NCT02649985) | Brigham and Women's Hospital | 2016-05-02 |
| Low Dose RT to Reduce Cerebral Amyloidosis in Early Alzheimer's (NCT02769000) | Virginia Commonwealth University | 2016-05-01 |
| Control and Intervention Programme on Alzheimer's Disease Risk Factors (NCT02772523) | Barcelonabeta Brain Research Center, Pasqual Maragall Foundation | 2016-05-01 |
| Neurostimulation and Cognitive Intervention in Alzheimer's Disease (NCT02772185) | Federal University of Paraíba | 2016-05-01 |
| Longitudinal Quantitative Susceptibility Mapping (QSM) in Alzheimer 's Disease (NCT02752750) | Medical University of Graz | 2016-05-01 |
| EEG/ERP Longitudinal Study in Alzheimer's Disease (AD) (NCT02769234) | Neuronetrix, Inc. | 2016-05-01 |
| Absolute Bioavailability of a Single, Fixed Subcutaneous Dose of Aducanumab in Healthy Participants (NCT02782975) | Biogen | 2016-05-01 |
| 12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Extension (NCT02586909) | Axovant Sciences Ltd. | 2016-04-26 |
| A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD) (NCT02754830) | Eli Lilly and Company | 2016-04-25 |
| Patient-Centred Innovations for Persons With Multimorbidity - Quebec (NCT02789800) | Université de Sherbrooke | 2016-04-22 |
| Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's Disease (NCT02787746) | Beijing Friendship Hospital | 2016-04-01 |
| A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD). (NCT02670083) | Hoffmann-La Roche | 2016-03-22 |
| Omental Transposition Surgery for Mild Alzheimer's Disease (NCT02349191) | Bariatric Medicine Institute, Salt Lake City, UT | 2016-03-01 |
| 24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease (NCT02579252) | Axon Neuroscience SE | 2016-03-01 |
| DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepezil (NCT02711683) | First Affiliated Hospital Xi'an Jiaotong University | 2016-03-01 |
| An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease (NCT02756858) | Anavex Life Sciences Corp. | 2016-03-01 |
| Caregiver Burden and Depression: Caring for Those Who Care for Others (NCT02690896) | University of Central Florida | 2016-02-24 |
| Relative Bioavailability Study in Healthy Subjects to Evaluate the Pharmacokinetics of HTL0009936 After One Dose of Prototype Formulation (NCT02710188) | Nxera Pharma UK Limited | 2016-02-01 |
| Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil). (NCT02695004) | Dongkook Pharmaceutical Co., Ltd. | 2016-02-01 |
| BEAM: Brain-Eye Amyloid Memory Study (NCT02524405) | Sunnybrook Health Sciences Centre | 2016-02-01 |
| Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study (NCT02420756) | American College of Radiology | 2016-02-01 |
| A Validation Study of the Novel Application of Telehealth in Clinical Drug Development in Subjects With Mild Cognitive Deficits (NCT02778438) | Quintiles, Inc. | 2016-02-01 |
| Enhancing Working Memory in Patients With Early Alzheimer's Disease Through the Use of rTMS (NCT02537496) | Centre for Addiction and Mental Health | 2016-01-14 |
| Patient-Centred Innovations for Persons With Multimorbidity - Ontario (NCT02742597) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2016-01-12 |
| [18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease (NCT02656498) | Jae Seung Kim | 2016-01-11 |
| [11C]MK-6884 Positron Emission Tomography (PET) Tracer Validation Trial (MK-6884-001) (NCT02621606) | Merck Sharp & Dohme LLC | 2016-01-08 |
| Support by Singing Sessions on Physical and Moral Pain : Assessment of Its Effectiveness in Alzheimer's Disease (NCT02670993) | Centre Hospitalier Universitaire de Saint Etienne | 2016-01-01 |
| Apathy in Dementia Methylphenidate Trial 2 (NCT02346201) | Johns Hopkins Bloomberg School of Public Health | 2016-01-01 |
| Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Volunteers (14 Day Multiple Ascending Dose) (NCT02537938) | NeuroGenetic Pharmaceuticals Inc | 2016-01-01 |
| Biodistribution, Pharmacokinetics, and Safety of F-18 THK-5351 PET in Alzheimer's Disease Patients and Healthy Subjects.(Positron Emission Tomograph ) (NCT02686216) | Chang Gung Memorial Hospital | 2015-12-01 |
| EEG-cholinergic Index and Clinical Response to Treatment With Cholinesterase Inhibitors (NCT02623764) | Landspitali University Hospital | 2015-12-01 |
| A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD) (NCT02614131) | Eli Lilly and Company | 2015-12-01 |
| BPN14770 Single Ascending Dose Study in Healthy Male and Female Subjects (NCT02648672) | Tetra Discovery Partners | 2015-12-01 |
| Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment (NCT02573740) | AbbVie | 2015-12-01 |
| Identification of Early Markers of Alzheimer's Disease by Using Eye Tracking in Reading. (NCT02557464) | Centre Hospitalier Universitaire de Nice | 2015-11-10 |
| Role of Hypoxia Ans Sleep Fragmentation in Alzheimer's Disease. and Sleep Fragmentation. (NCT02814045) | Sociedad Española de Neumología y Cirugía Torácica | 2015-11-01 |
| A Study Assessing Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease (NCT02431468) | Neurotrope Bioscience, Inc. | 2015-11-01 |
| Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION) (NCT02615002) | Neurim Pharmaceuticals Ltd. | 2015-11-01 |
| Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Alzheimer's Disease (NCT02912169) | Ageless Regenerative Institute | 2015-11-01 |
| [18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001) (NCT02562989) | Merck Sharp & Dohme LLC | 2015-10-19 |
| Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study (NCT02585934) | Axovant Sciences Ltd. | 2015-10-01 |
| Evaluate the Safety, Tolerability, Immunogenicity and Efficacy of UB-311 in Mild Alzheimer's Disease (AD) Patients (NCT02551809) | United Neuroscience Ltd. | 2015-10-01 |
| Medium Chain Triglycerides and Brain Metabolism in Alzheimer's Disease (NCT02709356) | Université de Sherbrooke | 2015-10-01 |
| Tools for Distance Delivery of an Evidence-based AD Family Caregiver Intervention (NCT02347202) | NYU Langone Health | 2015-10-01 |
| Phase 1 Study Investigating Effects of HTL0009936 on Cognition and BOLD fMRI Signals in Healthy Elderly Subjects (NCT02546310) | Nxera Pharma UK Limited | 2015-10-01 |
| Brain Sleep Clearance of Amyloid-Beta Peptides (NCT02474251) | NYU Langone Health | 2015-10-01 |
| Monetary Cost of Alzheimer's Disease in China (NCT02694445) | Beijing Friendship Hospital | 2015-10-01 |
| 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease (NCT02484547) | Biogen | 2015-09-15 |
| Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease (NCT02547818) | AZTherapies, Inc. | 2015-09-15 |
| Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease (NCT05040048) | Institut National de la Santé Et de la Recherche Médicale, France | 2015-09-04 |
| 18F-AV-1451 Autopsy Study (NCT02516046) | Avid Radiopharmaceuticals | 2015-09-01 |
| SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study (NCT02580305) | Suven Life Sciences Limited | 2015-09-01 |
| Effectiveness of Home-based Electronic Cognitive Therapy in Alzheimer's Disease (NCT02521558) | Boston University | 2015-09-01 |
| CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease (NCT03938870) | Washington University School of Medicine | 2015-08-18 |
| Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease (NCT02471196) | Orion Corporation, Orion Pharma | 2015-08-14 |
| 221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease (NCT02477800) | Biogen | 2015-08-13 |
| Dose-ranging Safety and Tolerability Study in Subjects ≥60 Years of Age (NCT02576639) | Novartis Pharmaceuticals | 2015-08-10 |
| Knowing and Remembering: Cognitive and Neural Influences of Familiarity on Recognition Memory in Early Alzheimer's Disease (NCT02492529) | Rennes University Hospital | 2015-07-21 |
| Brain-Computer Interface System for Training Memory and Attention in Elderly (NCT02228187) | Duke-NUS Graduate Medical School | 2015-07-01 |
| Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine (NCT02246075) | FORUM Pharmaceuticals Inc | 2015-07-01 |
| Alzheimer's Disease and Physiological, Cognitive Function and BDNF Levels of Plasma Adaptation After Exercise Training (NCT02968875) | University Hospital Center of Martinique | 2015-07-01 |
| Feasibility Study in Subjects With Mild to Moderate Alzheimer's Disease (NCT02560753) | T3D Therapeutics, Inc. | 2015-07-01 |
| Single and Multiple Ascending Dose Study of Aducanumab (BIIB037) in Japanese Participants With Alzheimer's Disease (NCT02434718) | Biogen | 2015-06-24 |
| Intermittent Calorie Restriction, Insulin Resistance, and Biomarkers of Brain Function (NCT02460783) | National Institute on Aging (NIA) | 2015-06-22 |
| Non-invasive Stimulation of Brain Networks and Cognition in Alzheimer's Disease and Frontotemporal Dementia (NCT03422250) | IRCCS Centro San Giovanni di Dio Fatebenefratelli | 2015-06-08 |
| Pathological and Non-pathological Aging, Physical Activity, Genotype and Cognition (NCT02520232) | University Hospital, Bordeaux | 2015-06-01 |
| Webnovela for Hispanic Dementia Family Caregivers (NCT02489110) | Photozig, Inc. | 2015-06-01 |
| In Vivo Imaging of Therapeutic Electric Current Flow (NCT02453763) | University of Florida | 2015-06-01 |
| Preventing Loss of Independence Through Exercise (PLIE) in Persons With Dementia (NCT02350127) | VA Office of Research and Development | 2015-05-04 |